New Alzheimer’s Medication Has Slow Launch in the US – Here’s Why! Leqembi, a medication for Alzheimer’s disease, received FDA approval in early January. The FDA’s accelerated pathway, which permits drug launches… February 6, 2023 · by Katherine Baldwin · 0
